These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21136899)

  • 1. Clinical application of antibody microarray in chronic kidney disease: How far to go?
    Lv LL; Liu BC
    Proteomics Clin Appl; 2008 Jul; 2(7-8):989-96. PubMed ID: 21136899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
    Liu BC; Zhang L; Lv LL; Wang YL; Liu DG; Zhang XL
    Am J Nephrol; 2006; 26(5):483-90. PubMed ID: 17095863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal fibrosis: insight from proteomics in animal models and human disease.
    Klein J; Kavvadas P; Prakoura N; Karagianni F; Schanstra JP; Bascands JL; Charonis A
    Proteomics; 2011 Feb; 11(4):805-15. PubMed ID: 21229585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
    Spasovski G; Ortiz A; Vanholder R; El Nahas M
    Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and chronic kidney disease: new understanding of an old problem.
    Kang DH; Chen W
    Semin Nephrol; 2011 Sep; 31(5):447-52. PubMed ID: 22000652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executing change in the management of chronic kidney disease: perspectives on guidelines and practice.
    Levin A; Stevens LA
    Med Clin North Am; 2005 May; 89(3):701-9. PubMed ID: 15755474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The German Chronic Kidney Disease (GCKD) study: design and methods.
    Eckardt KU; Bärthlein B; Baid-Agrawal S; Beck A; Busch M; Eitner F; Ekici AB; Floege J; Gefeller O; Haller H; Hilge R; Hilgers KF; Kielstein JT; Krane V; Köttgen A; Kronenberg F; Oefner P; Prokosch HU; Reis A; Schmid M; Schaeffner E; Schultheiss UT; Seuchter SA; Sitter T; Sommerer C; Walz G; Wanner C; Wolf G; Zeier M; Titze S
    Nephrol Dial Transplant; 2012 Apr; 27(4):1454-60. PubMed ID: 21862458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital].
    Sumaili EK; Krzesinski JM; Cohen EP; Nseka NM
    Nephrol Ther; 2010 Jul; 6(4):232-9. PubMed ID: 20409770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease in the United States: a public policy imperative.
    Rettig RA; Norris K; Nissenson AR
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1902-10. PubMed ID: 18922986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.
    Levey AS; Schoolwerth AC; Burrows NR; Williams DE; Stith KR; McClellan W;
    Am J Kidney Dis; 2009 Mar; 53(3):522-35. PubMed ID: 19231739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic viral hepatitis and chronic kidney disease.
    Chacko EC; Surrun SK; Mubarack Sani TP; Pappachan JM
    Postgrad Med J; 2010 Aug; 86(1018):486-92. PubMed ID: 20709771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease management in chronic kidney disease.
    Rastogi A; Linden A; Nissenson AR
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Apolipoprotein AI as a serum biomarker of chronic kidney disease in liver transplant recipients, using proteomic techniques.
    O'Riordan A; Johnston O; McMorrow T; Wynne K; Maguire P; Hegarty JE; McCormick A; Watson AJ; Cagney G; Gallagher WM; Ryan MP
    Proteomics Clin Appl; 2008 Sep; 2(9):1338-48. PubMed ID: 21136927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study].
    De Nicola L; Donfrancesco C; Minutolo R; Lo Noce C; De Curtis A; Palmieri L; Iacoviello L; Conte G; Chiodini P; Sorrentino F; Coppo R; Vanuzzo D; Scherillo M; Giampaoli S
    G Ital Nefrol; 2011; 28(4):401-7. PubMed ID: 21809309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and cardiovascular risk.
    Yerram P; Karuparthi PR; Hesemann L; Horst J; Whaley-Connell A
    J Am Soc Hypertens; 2007; 1(3):178-84. PubMed ID: 20409850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.